These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36457743)

  • 1. Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma.
    Yousuf T; Dar SB; Bangri SA; Choh NA; Rasool Z; Shah A; Rather RA; Rah B; Bhat GR; Ali S; Afroze D
    Front Genet; 2022; 13():929787. PubMed ID: 36457743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-155, miR-96 and miR-99a as potential diagnostic and prognostic tools for the clinical management of hepatocellular carcinoma.
    Ning S; Liu H; Gao B; Wei W; Yang A; Li J; Zhang L
    Oncol Lett; 2019 Sep; 18(3):3381-3387. PubMed ID: 31452818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Yu B; Zhou S; Liang H; Ye Q; Wang Y
    Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y; Yan D; Wang L; Zhang J; He Q
    J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
    World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
    Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
    Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study.
    Liu AM; Yao TJ; Wang W; Wong KF; Lee NP; Fan ST; Poon RT; Gao C; Luk JM
    BMJ Open; 2012; 2(2):e000825. PubMed ID: 22403344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.
    Moshiri F; Salvi A; Gramantieri L; Sangiovanni A; Guerriero P; De Petro G; Bassi C; Lupini L; Sattari A; Cheung D; Veneziano D; Nigita G; Shankaraiah RC; Portolani N; Carcoforo P; Fornari F; Bolondi L; Frassoldati A; Sabbioni S; Colombo M; Croce CM; Negrini M
    Oncotarget; 2018 Mar; 9(20):15350-15364. PubMed ID: 29632649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma.
    Zhang Y; Li T; Qiu Y; Zhang T; Guo P; Ma X; Wei Q; Han L
    Medicine (Baltimore); 2017 Jan; 96(2):e5642. PubMed ID: 28079796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.